XOMA Corporation (XOMA)

[offshore48]

Yes there have been all sorts of rumors floated on other forums time and time again with total disregard for what is discussed in the quarterly calls or even after the Eyeguard B miss. This is counterproductive to the extreme. Take today's action in the afternoon from roughly 12 pm until close. For the majority of the time we traded in a 1 cent range 1.45-1.46 for hours, as tight a range as you can practically have without going fractional. So what does that mean? A tight spread or a wide one, what does that traditionally mean? Point is any little nuance can be overblown, disregarded or whatever. Discussed or not, the focus remains on the Norvatis deal. Not to long ago they were listed as a competitor to Xoma! Imagine that, a quarter of a trillion dollar company a competitor to a tiny biotech firm in development and not commercialization at all. Now, the competitor becomes a partner and strokes a check for operations that help to serve it's interests as highly meaningful results are awaited. What does that sound like to anyone? A rumor? Hardly. A foot in the door? To what end? Bottom line, what is Norvatis's end game? Xoma will stay in this trading pattern until the news comes out that changes things. I again submit that if everyone would study the history of Norvartis and its business model in this area, the answers are punch in the face obvious. In the meantime, trade the chart if you want. That will pass the time for now.